CDD3505
CDD3505 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepatic cytochrome P450IIIA (CYP3A) activity.
Product Specifications
CAS Number
[173865-33-3]
UNSPSC
12352005
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/CDD3505.html
Concentration
10mM
Purity
98.0
Solubility
DMSO : 14.29 mg/mL (ultrasonic)
Smiles
O=[N+]([O-])C1=CN(C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C=N1
Molecular Formula
C22H17N3O2
Molecular Weight
355.39
References & Citations
[1]Method for increasing HDL cholesterol levels?using?heteroaromatic phenylmethanes. United States Patent 6103733
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1156964-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli Fructokinase (cscK)
Ask
View Details MBS1156964-06 0.02 mg (Mammalian-Cell)
Recombinant Escherichia coli Fructokinase (cscK)
Ask
View Details